U.S. regulation of chemicals is in need of an overhaul, informed by European legislation and guided by new thinking about risk.
No takes yet. Share an insight, caveat, or question.
Schwarzman et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: